Koninklijke Philips N.V. $PHG Shares Acquired by Hantz Financial Services Inc.

Hantz Financial Services Inc. increased its holdings in shares of Koninklijke Philips N.V. (NYSE:PHG) by 7.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 72,798 shares of the technology company’s stock after purchasing an additional 4,937 shares during the period. Hantz Financial Services Inc.’s holdings in Koninklijke Philips were worth $1,746,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Bessemer Group Inc. boosted its stake in Koninklijke Philips by 2,935.4% during the 1st quarter. Bessemer Group Inc. now owns 1,973 shares of the technology company’s stock worth $51,000 after purchasing an additional 1,908 shares during the period. Whipplewood Advisors LLC boosted its stake in Koninklijke Philips by 39.1% during the 2nd quarter. Whipplewood Advisors LLC now owns 2,108 shares of the technology company’s stock worth $51,000 after purchasing an additional 592 shares during the period. Caitong International Asset Management Co. Ltd boosted its stake in Koninklijke Philips by 1,170.3% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,439 shares of the technology company’s stock worth $62,000 after purchasing an additional 2,247 shares during the period. Blue Trust Inc. boosted its stake in Koninklijke Philips by 30.0% during the 2nd quarter. Blue Trust Inc. now owns 4,408 shares of the technology company’s stock worth $106,000 after purchasing an additional 1,017 shares during the period. Finally, Wealthquest Corp acquired a new stake in Koninklijke Philips during the 1st quarter worth $116,000. Institutional investors and hedge funds own 13.67% of the company’s stock.

Koninklijke Philips Stock Up 0.3%

Shares of Koninklijke Philips stock opened at $27.36 on Friday. The company has a market cap of $26.34 billion, a P/E ratio of 143.99, a PEG ratio of 0.70 and a beta of 0.82. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.81 and a current ratio of 1.26. Koninklijke Philips N.V. has a one year low of $21.48 and a one year high of $29.28. The firm has a fifty day moving average of $27.84 and a two-hundred day moving average of $25.72.

Koninklijke Philips (NYSE:PHG) last announced its quarterly earnings data on Tuesday, July 29th. The technology company reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.12. The company had revenue of $5.05 billion during the quarter, compared to the consensus estimate of $4.35 billion. Koninklijke Philips had a net margin of 1.00% and a return on equity of 11.95%. On average, analysts forecast that Koninklijke Philips N.V. will post 1.63 earnings per share for the current year.

Wall Street Analyst Weigh In

PHG has been the subject of a number of recent research reports. Weiss Ratings reiterated a “sell (d+)” rating on shares of Koninklijke Philips in a research note on Wednesday, October 8th. Wall Street Zen cut shares of Koninklijke Philips from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Koninklijke Philips has an average rating of “Moderate Buy”.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.